申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:US10875888B2
公开(公告)日:2020-12-29
The present invention relates to a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt thereof, and relates to applications thereof in the preparation of drugs for treating FXR related diseases.
本发明涉及由式(I)代表的化合物、其同系物或其药学上可接受的盐,并涉及其在制备治疗 FXR 相关疾病的药物中的应用。